Author:
Al Ali Lawien,Meijers Wouter C.,Beldhuis Iris E.,Groot Hilde E.,Lipsic Erik,van Veldhuisen Dirk J.,Voors Adriaan A.,van der Horst Iwan C. C.,de Boer Rudolf A.,van der Harst Pim
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Talman, V. & Ruskoaho, H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 365, 563–581 (2016).
2. Kakkar, R. & Lee, R. T. The IL-33/ST2 pathway: Therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 7, 827–840 (2008).
3. Weinberg, E. O. et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107, 721–726 (2003).
4. Liu, F. T. et al. Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147, 1016–1028 (1995).
5. Sharma, U. C. et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110, 3121–3128 (2004).